10-Q: Jena Acquisition II Reports Q3 2025; Trust Account Grows

Jena Acquisition Corporation II, a blank check company, reported a net income of $2.29 million for Q3 2025, driven by interest earned on its growing $233.18 million Trust Account, as it continues its search for a business combination.

Summary

• Jena Acquisition Corporation II (JENA) is a Special Purpose Acquisition Company (SPAC) incorporated on February 24, 2025, with the sole purpose of effecting a business combination.
• The company has not commenced any operations or generated operating revenue to date, with activities focused on formation, its Initial Public Offering (IPO), and identifying acquisition candidates.
• For the three months ended September 30, 2025, the company reported a net income of $2,286,119, primarily from $2,418,248 in dividend and interest earned on investments held in the Trust Account.
• From inception (February 24, 2025) through September 30, 2025, the company recorded a net loss of $3,983,770, which includes $6,900,000 in advisory fee expense and $263,558 in general and administrative costs, partially offset by $3,179,788 in interest income.
• As of September 30, 2025, the Trust Account held $233,179,788, up from the initial $230,000,000 placed after the May 30, 2025 IPO and private placement.
• The company has until May 30, 2027, to complete an initial business combination, or it will be required to redeem its public shares.
• Current cash outside the Trust Account is $1,101,596, with working capital of $1,127,460, deemed sufficient for operating needs for at least one year from the financial statement issuance date.
• Outstanding shares as of November 14, 2025, include 23,225,000 Class A Ordinary Shares and 5,750,000 Class B Ordinary Shares.

Sentiment

Score: 6

Explanation: The company is performing as expected for a SPAC in its early stages, with the Trust Account growing due to interest income. However, the significant accumulated net loss from inception due to advisory fees and the inherent risks of finding a suitable business combination within the deadline temper the sentiment. The effective disclosure controls are a positive, but the lack of a definitive target and the potential for dilution or further capital raises introduce uncertainty.

Positives

• The Trust Account has grown to $233,179,788 as of September 30, 2025, from an initial $230,000,000, generating $3,179,788 in dividend and interest income since inception.
• The company reported a net income of $2,286,119 for the three months ended September 30, 2025.
• Management believes the company has sufficient funds for working capital needs for at least one year from the date of issuance of the financial statements.
• The underwriters' Over-Allotment Option for 3,000,000 Option Units was fully exercised, indicating strong initial demand for the IPO.
• Disclosure controls and procedures were evaluated and concluded to be effective as of September 30, 2025.

Negatives

• The company reported a net loss of $3,983,770 from inception (February 24, 2025) through September 30, 2025, primarily due to significant advisory fee expenses of $6,900,000.
• The company has not yet identified a definitive business combination target, and there is no assurance that it will be able to successfully effect a business combination within the required timeframe.
• Significant deferred fees ($6,900,000) and advisory fees ($6,900,000) are payable upon the closing of an initial business combination, which will reduce the funds available for the target business.
• The Sponsor's ability to satisfy indemnity obligations is uncertain, as its only assets are believed to be company securities.
• Potential for material dilution to Public Shareholders if the Class B Ordinary Share conversion ratio is adjusted in connection with a business combination.

Risks

• Inability to complete an initial Business Combination within the Combination Period (by May 30, 2027), which would lead to liquidation and redemption of public shares.
• The proceeds deposited in the Trust Account could become subject to claims of the company's creditors, potentially having priority over public shareholders.
• The Sponsor may not have sufficient funds to satisfy its indemnity obligations, as its only assets are believed to be company securities.
• The company may have insufficient funds available to operate its business prior to the initial Business Combination if estimates of costs for identifying and negotiating a target are less than actual amounts.
• The company may need to obtain additional financing to complete a Business Combination or if a significant number of Public Shares are redeemed.
• Risk of being deemed an investment company under the Investment Company Act of 1940, which increases the longer funds are held in the Trust Account.
• Adverse effects on the company's ability to complete a Business Combination due to changes in laws or regulations, downturns in financial markets, economic conditions, inflation, interest rate fluctuations, tariffs, supply chain disruptions, declines in consumer confidence, public health considerations, and geopolitical instability (e.g., military conflicts in Ukraine and the Middle East).
• The NYSE Rules require SPACs to complete their initial Business Combination within three years of initial listing (NYSE Three Year Requirement), failure of which could lead to trading suspension and delisting.
• Holders of Rights will not receive any funds from the Trust Account if the company liquidates without completing a Business Combination, and their Rights may expire worthless.

Future Outlook

The company continues to actively identify and evaluate prospective acquisition candidates for a business combination, which it must complete by May 30, 2027. Management believes it has sufficient working capital for at least the next year but acknowledges the potential need for additional financing if a significant number of public shares are redeemed or if transaction costs exceed estimates. The company may also instruct the trustee to liquidate Trust Account investments into cash to mitigate investment company risk.

Management Comments

• Management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination.
• The Company does not believe that it will need to raise additional funds in order to meet the expenditures required for operating its business.
• However, if the Company's estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the Initial Business Combination.
• Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because the Company becomes obligated to redeem a significant number of Public Shares upon completion of the Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination.
• Certifying Officers concluded that our disclosure controls and procedures were effective as of September 30, 2025.

Industry Context

Jena Acquisition Corporation II operates as a Special Purpose Acquisition Company (SPAC) in a market that has seen fluctuating investor sentiment and increased regulatory scrutiny. Like many SPACs, it faces a deadline to complete a business combination, which for Jena II is May 30, 2027. The company's focus on generating interest income from its Trust Account is standard practice for SPACs during their search phase, aiming to preserve capital and potentially increase the redemption value for public shareholders. The significant deferred and advisory fees are typical for SPAC structures, representing compensation for underwriters and advisors contingent on a successful merger. The challenge for Jena II, as with all SPACs, is to identify a suitable target business that meets the 80% fair market value threshold and successfully navigate the complexities of a business combination within the stipulated timeframe, amidst a competitive landscape for attractive private companies.

Comparison to Industry Standards

• The initial IPO price of $10.00 per unit and the current redemption value of $10.14 per share are standard for SPACs, reflecting the accumulation of interest in the Trust Account.
• The 24-month timeline to complete a business combination (May 30, 2027) is a common duration for SPACs, aligning with typical industry expectations and NYSE listing rules.
• The structure of the units (one Class A Ordinary Share and one-twentieth of one Right) and the conversion of Founder Shares are standard SPAC mechanisms.
• The deferred underwriting fee of 3.0% ($6,900,000) and an additional advisory fee of 3.0% ($6,900,000) are within the typical range of fees paid to underwriters and advisors in SPAC transactions, though these represent a substantial portion of the initial gross proceeds.
• The investment strategy for the Trust Account, primarily in U.S. government treasury obligations or money market funds, is standard practice to preserve capital and generate minimal returns while awaiting a business combination.
• The company's current cash position outside the Trust Account ($1,101,596) and working capital ($1,127,460) appear adequate for its current operational phase, similar to other SPACs in their pre-deal stage.

Corporate Governance

Related Party Transactions

• The Sponsor made a capital contribution of $25,000 for 5,750,000 Class B Ordinary Shares (Founder Shares).
• The Sponsor transferred 30,000 Founder Shares to three independent directors for their services.
• The Sponsor loaned the company up to $300,000 via an IPO Promissory Note, of which $223,877 was repaid.
• The company pays the Sponsor $2,500 per month for administrative services under an Administrative Services Agreement.
• The Sponsor or affiliates or certain officers and directors may provide Working Capital Loans, up to $1,500,000, convertible into units.

Stakeholder Impact

• Shareholders (Public Shares): Potential for redemption at $10.14 per share if a business combination is not completed, or if they choose to redeem in connection with a business combination or charter amendment. Risk of dilution from Class B share conversion or future capital raises.
• Shareholders (Founder Shares/Sponsor): Waived redemption rights and rights to liquidating distributions from the Trust Account for Founder Shares if no business combination. Entitled to liquidating distributions for any Public Shares they hold.
• Underwriters/Santander: Entitled to significant deferred fees ($6,900,000) and advisory fees ($6,900,000) upon the successful completion of a business combination.
• Creditors: Proceeds in the Trust Account could become subject to claims of creditors, potentially having priority over public shareholders.

Next Steps

• Continue identifying and evaluating prospective acquisition candidates for a business combination.
• Structure, negotiate, and complete an initial Business Combination by May 30, 2027.
• Potentially instruct the trustee to liquidate Trust Account investments into cash to mitigate Investment Company Act risk.
• Manage and forecast cash to ensure sufficient capital for operations and transaction costs.

Key Dates

Recommendation

Jena Acquisition Corporation II is operating as a typical SPAC in its early stages, successfully completing its IPO and growing its Trust Account through interest income. The company has a clear timeline to May 30, 2027, to find a business combination. While the accumulated net loss from inception is notable due to advisory fees, this is a common characteristic of SPACs pre-deal. The primary investment thesis for a SPAC at this stage is its ability to identify and execute a compelling business combination. Until a definitive target is announced, the stock is essentially a cash-equivalent instrument with upside potential from a successful deal and downside protection from the Trust Account's redemption value. Given the current status, a 'hold' recommendation is appropriate, awaiting further developments regarding a potential merger target. Investors should monitor progress towards a business combination and the potential impact of significant deferred and advisory fees on the post-combination entity.

Keywords

SPAC, Special Purpose Acquisition Company, Business Combination, Jena Acquisition Corporation II, 10-Q, Quarterly Report, Trust Account, IPO, Merger, Acquisition, Financials, SEC Filing, Blank Check Company, Corporate Governance, Risk Factors